During the past decade, Detroit Medical Center Cardiovascular Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Detroit Medical Center Cardiovascular Institute" are "Severe Aortic Stenosis" (3 trials), "Aortic Stenosis" (1 trials), "Heart Failure" (1 trials), "NYHA Class III Heart Failure" (1 trials) and "NYHA Class IV Heart Failure" (1 trials). Many other conditions were trialed in "Detroit Medical Center Cardiovascular Institute" in a lesser frequency.

Most popular intervention types in "Detroit Medical Center Cardiovascular Institute" are "Device" (6 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (3 trials), "BAROSTIM NEO® System" (1 trials), "CoreValve Evolut R TAVR system" (1 trials), "Medical Management" (1 trials) and "No intervention: Optimal medical therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Detroit Medical Center Cardiovascular Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Detroit Medical Center Cardiovascular Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Detroit Medical Center Cardiovascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Detroit Medical Center Cardiovascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".